Catalyst Pharmaceuticals
CPRX
$23.10
Share price
-0.52%
Change (1 day)
54.00%
Change (1 year)
Categories
Operating Margin for Catalyst Pharmaceuticals (CPRX)
Operating Margin as of June 2025 (TTM): 48.34%
According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 48.34%. At the end of 2024 the company had an Operating Margin of 39.68%.
Operating Margin history for Catalyst Pharmaceuticals from 2019 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 39.68% | 82.01% |
| 2023 | 21.80% | -54.14% |
| 2022 | 47.54% | 27.81% |
| 2021 | 37.20% | 7.23% |
| 2020 | 34.69% | 11.51% |
| 2019 | 31.11% | -100.44% |
| 2018 | -7,059.03% | |
| 2010 | -823.01% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 BioMarin Pharmaceutical BMRN | 22.85% | -52.73% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -7.35% | -115.20% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 18.78% | -61.15% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | -274.80% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | -73.93% | 🇺🇸 USA |
 Abbott Laboratories ABT | 17.36% | -64.09% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.